6Z4:FRA
Crinetics Pharmaceuticals Inc
€71.58
0.00%
(0.00) 1D
Aug 31, 9:06:04 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 6Z4...
Mkt. cap
9.01B
Avg. vol.
0.00
Volume
0.00
52-wk high
€73.08
52-wk low
€26.40
No. of employees
594
Mkt. cap
9.01B
Avg. vol.
0.00
Volume
0.00
52-wk high
€73.08
52-wk low
€26.40
No. of employees
594
News stories
From web sources and news partners
ad-hoc-news.de
·
20 hours ago
Vertex Pharma stock falls as market digests Crinetics deal and valuation risks
Quiver Quantitative
·
1 day ago
Vertex shares fall as investors digest Crinetics acquisition and related financing plans
Profile
Crinetics Pharmaceuticals was a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
In July 2026, Vertex Pharmaceuticals agreed to acquire the company for $10 billion. The acquisition closed in September of 2026. Wikipedia
About Crinetics Pharmaceuticals Inc